Changing Cancer Treatment Therapies through ADCs-Clay Siegall and Seattle Genetics

Dr. Clay Siegall is the co-founder of Seattle Genetics. The company was founded in 1998 and has been the president and CEO since 2002. He also serves as the chairman of the board of directors. He then worked with the National Cancer Institute, National Institute of Health (1988-1991). Before Seattle Genetics, Dr. Siegall used to work for Bristol-Myers Squibb Pharmaceutical Research Institute (1991-1997).

Dr. Siegall was affected by cancer early on in life when his father was diagnosed with it. He was only 19 at the time, and this became his driving force to be what he is today. His father passed on when he was 24. His only goal in the world is to provide better treatment for cancer patients. He has been doing this for the last 30 years and has no intention of stopping soon. His advice to young entrepreneurs is to interact with smart people who have expertise and experience and learn as much as you can.

Seattle Genetics was founded with a vision of developing innovative biotechnological research with the aim of helping patients. The company has several licenses including with Pfizer. Under the leadership of Dr. Siegall, the company has generated more than $1.2 billion through public and private funding. The funding has allowed the company to continue to be a trailblazer in advancing cancer treatment through innovative technology. His scientific mind and visionary leadership make him a very rare type of individual. He is propelling not only his company but the entire industry to new heights. Under Dr. Siegall the company has entered into multiple strategic licenses for their ADC technology, which has, in turn, made them industry leaders in the field of antibody-drug conjugates. With the FDA approval of the companies’ first ADC product, ADCENTRIS the company has generated more than $350 million to date. With the drug now approved in more than 65 countries.

Dr.Siegall holds a Ph.D. in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland. He has more than 70 publications on his resume and holds 15 patents. Dr.Siegall has received several awards. In 2012 he was awarded Pacific Northwest Ernst & Young Entrepreneur of the Year and in 2013 the University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences.